CARB-X global partnership headed toward developing an innovative vaccine against potentially deadly Staphylococcus aureus bacteria that could be a “game
IBT CEO Dr. M. Javad Aman will discuss the development of a multi-component toxoid vaccine for S. aureus and the
[Rockville, MD, April 2025] A promising new therapeutic is being
IBT Bioservices Transforms Identity, Elevates Focus on Contract Research Services
CARB-X global partnership headed toward developing an innovative vaccine against
Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.
